Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

ABUSED WOMENS AID IN CRISIS INC

UEI: JKDLUZ2TQWM3CAGE: 4ETQ2

ABUSED WOMENS AID IN CRISIS INC is a federal contractor, registered under UEI JKDLUZ2TQWM3 and CAGE code 4ETQ2. It has been awarded $11,327,015 in federal contracts. Primary work spans Unknown NAICS. Top awarding agencies include Department Of Justice (doj), Department Of Housing And Urban Development, and Department Of Justice.

Contact Information

Registration and classification details

Registration

UEI Code

JKDLUZ2TQWM3

CAGE Code

4ETQ2

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Domestic ShelterNon-Profit Organization

NAICS Codes

624221Temporary Shelters(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ABUSED WOMENS AID IN CRISIS INC operates as a nonprofit service provider focused on crisis intervention and support for survivors of domestic violence and gender-based abuse. Leveraging its primary NAICS code 624221, which classifies it under “Other Social Assistance Activities,” the organization de...

ABUSED WOMENS AID IN CRISIS INC operates as a nonprofit service provider focused on crisis intervention and support for survivors of domestic violence and gender-based abuse. Leveraging its primary NAICS code 624221, which classifies it under “Other Social Assistance Activities,” the organization delivers direct human services including emergency shelter, safety planning, counseling, advocacy, and community outreach. Its core capabilities center on trauma-informed care, case management, and coordination with law enforcement and social service networks to ensure holistic support for vulnerable populations. The organization specializes in culturally responsive interventions tailored to underserved communities in Alaska, with an emphasis on geographic accessibility in remote and rural regions. While no certifications are held, its operational model is grounded in best practices for victim-centered services, including confidentiality protocols, multidisciplinary team coordination, and crisis response protocols aligned with state and federal guidelines for domestic violence assistance. No award history is available to infer specific agency partnerships or contract-based performance. Consequently, there is no demonstrable track record of federal contracting activity or formal relationships with government departments. The organization’s industry focus is exclusively within social assistance services, specifically addressing intimate partner violence and crisis stabilization. It does not engage in IT, infrastructure, or procurement-based government contracting, positioning itself as a community-based service provider rather than a federal vendor. ABUSED WOMENS AID IN CRISIS INC is structured as a nonprofit entity with an 8H designation, indicating it is a Native American-owned concern. It operates primarily from Anchorage, Alaska, serving the broader Alaska region. Its government market positioning is non-contractual; it functions as a direct service provider funded through grants, donations, and state allocations rather than federal contracts.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

48

All time

Active

1

Currently performing

Completed

47

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with ABUSED WOMENS AID IN CRISIS INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ABUSED WOMENS AID IN CRISIS INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ABUSED WOMENS AID IN CRISIS INC's top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants include U.S.-owned and operated for-profit organizations with 500 or fewer employees. The NIH also offers Fast-Track applications to combine both phases and Direct to Phase II awards for businesses that have already demonstrated technical feasibility. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on scientific merit, commercial potential, and the team's ability to execute the project. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines. Additionally, recipients must maintain active SAM and UEI registrations and comply with federal cybersecurity incident reporting requirements, including notifying the HHS of any breaches within 48 hours.
Department of Health and Human Services

POSTED

6 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on technical merit and feasibility and Phase II advancing the technology toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with budget limits varying by participating institute, typically ranging from 400,000 to 700,000 dollars for Phase I and up to 3,000,000 dollars for Phase II. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the business environment. While clinical trials are generally optional, they are prohibited for specific components, including all FDA participating components and several NIH institutes. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. The current solicitation remains open for applications until April 6, 2027.
Department of Health and Human Services

POSTED

6 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, under solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage development to full commercialization. This program specifically targets recipients of prior active or ended NIH SBIR/STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including late-stage research and development, independent replication of key studies, manufacturing scale-up, and technical assistance such as regulatory strategy, intellectual property planning, and market research. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible projects may have a maximum performance period of three years, with budget ceilings varying by the participating NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via the NIH peer review system based on scientific and technical merit, commercial potential, and relevance to program priorities. Key requirements for applicants include maintaining active SAM and UEI registrations and submitting a detailed regulatory plan and progress report. It is important to note that while clinical trials are generally optional, several NIH components, including the NHLBI, NIAID, and NIDDK, do not accept clinical trials under this specific funding opportunity. Additionally, funds cannot be used for patent or FDA filing fees, nor can they include separate Technical and Business Assistance funding.
Department of Health and Human Services

POSTED

6 months ago

DEADLINE

in 5 months
View Details